A dramatic breakthrough in cancer gas surfaced with a new medical implant developed at Rice University in the US which could cure a patient’s cancer within just sixty days.
The medical implant could help save hundreds of thousands of cancer patients a year, according to scientists.
The scientists leading the charge claim that cancer patients in the future will not be stuck to “hospital beds, IV bags and external monitors”.
The ‘revolutionary’ research into the implant, which is smaller than a crayon has been awarded $45million, that is £36.8m, by the US government.
The three-inch device, which is implanted into the abdomen, could also be able to communicate wirelessly with smartphones and be chargeable “like an iWatch”.
The device is known as the hybrid advanced molecular manufacturing regulator or HAMMR, It works as both a cancer detection and drug administration system.
The HAMMR is loaded full of sensors that monitor fast-mutating cancer cells and adjust the release of immunotherapy drugs based on a patient’s response.
Omid Veiseh, who is leading the research, says the implant is “truly groundbreaking and could potentially save hundreds of thousands of lives each year”.
He said: “This is the type of research that makes a significant impact on the world”.
Dr Veiseh compared the technology to current treatments used for diabetes.
“This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump.
“But for cancer immunotherapy, it’s revolutionary”.
The implant could cure a patient’s cancer within just sixty days
The researchers claim the technology will be able to improve outcomes for cancers that are hard to treat, such as ovarian and pancreatic and slash cancer deaths by 50 percent in the US.
